drugset / Trial / NCT01289236

"MILNACIPRAN" in Subjects With Chronic Shoulder Pain

NCT01289236

Phase 4 Completed 40 enrolled Valera Bussell Forest Laboratories · collab
RandomizedParallel-groupSingle-blindTreatment

Summary

The purpose of this study is to compare the safety and efficacy of multiple doses of "Milnacipran" to a placebo dose in subjects with Chronic Shoulder Pain.

Timeline

Start
2009-10
Primary completion
2011-06
Completion
2011-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Milnacipran Other / unclassified 50 mg
Comparator Milnacipran Other / unclassified 100 mg

Indications